שווי כולל של החברה: allakos.com (ALLK)

The market trend for Allakos Inc. (ALLK) shares on the GURU.Markets platform is recorded at . Allakos Inc. develops anti-inflammatory antibodies, relying on existing cash reserves until it generates revenue. Its success within the immunology ecosystem is driven by FDA verdicts and clinical trial results; meanwhile, demand for chronic disease therapies remains stable and is virtually immune to economic cycles.

The value of Allakos Inc. (ALLK) is determined as the sum of market capitalization and net debt, reflecting the actual cost of a full business buyout. By analyzing the enterprise value on this chart, an investor sees the actual scale of assets required to maintain costly R&D in immunology and protect its patent monopoly, confirming the company's financial stability in the face of regulatory barriers.